ERVW-1 and HIV infectious disease: As a maternal and/or infant HIV vaccine will most likely be necessary for eliminating pediatric HIV infections, identifying the maternal NAbs that target specific vulnerable Env epitopes in selecting for neutralization-resistant viruses will be important to inform maternal vaccination strategies.